Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and its metabolites in
patients with mild renal impairment compared to their sex, age and weigh based healthy
volunteer counterparts.